Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Expert Rev Anticancer Ther. 2010 Jul;10(7):997–1008. doi: 10.1586/era.10.88

Figure 2. Mean concentration–time profile for 60 patients after receiving romidepsin 14 mg/m2 as a 4-h infusion.

Figure 2.

Each circle represents the mean concentration of romidepsin, at the mean collection time. X and Y error bars represent the standard deviation for concentration and sample collection time, respectively.